Effect of virtual reality associated with transcranial direct current stimulation to treat trunk control and improve autonomic response in people with spinal cord injury

Effect of combined therapy of virtual reality and stimulation transcranial direct current stimulation (tDCS) in the balance of trunk and autonomic modulation in people with spinal cord injury

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-3zkf2yc

Enrollment

Unknown

Registered

2021-05-14

Start date

2021-01-11

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Interventions

The protocol will include the execution of the following sequence of tasks: on the first day (D1), on the fifth (D5) and tenth day (D10) of intervention, trunk balance assessments will be carried out

pre-tests before the application of Transcranial Direct Current Stimulation - tDCS - (Coincident Timing - acquisition with 20 repetitions

Reaction Time (TRt) with 20 repetitions

Fitts law task with 3 attempts on 4 different difficulty indexes

Coincident Timing with 5 repetitions + 5 repetitions with increased level of speed - for retention and transfer analysis). There will be 10 sessions with the application of tDCS for 20 minutes, in whi

E02.760.169.063.500.387

E01.789.800

Eligibility

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All participants who agree to participate after reading and signing the Free and Informed Consent Term (FICT) will be included; with diagnosis of spinal cord injury - quadriplegic or paraplegic with neurological level equal to or greater than T6; age equal to or greater than 18 years and less than or equal to 60 years and with incomplete injuries.

Exclusion criteria

Exclusion criteria: Individuals who are not able to perform virtual reality tasks will be excluded; patients with severe heart disease; with metallic implants in the skull; deformities and / or absence of the skullcap; congenital anomalies; patients using drugs that interfere with the ANS (such as antiarrhythmics, insulin, beta-blockers); patients with associated brain injuries that have resulted in significant motor and cognitive deficits and individuals with a convulsive history.

Design outcomes

Primary

Measure	Time frame
Primary outcomes: improvement of the trunk control of the individuals assessed through the range test in different directions, mainly in the active ETCC group.	—

Secondary

Measure	Time frame
Secondary outcomes: verify greater heart rate variability in individuals during the protocol, especially in the active ETCC group.	—

Countries

Brazil

Contacts

Public ContactNadja Silva

moreiranadja@hotmail.com+55 011 985327860

Outcome results

None listed

Source: REBEC (via WHO ICTRP)